Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance.
- NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_assertion description "[Overall, our data show that collagen upregulation of MT1-MMP contributes to gemcitabine resistance in vitro and in a xenograft mouse model, and suggest that targeting MT1-MMP could be a novel approach to sensitize pancreatic tumors to gemcitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance.
- NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_assertion evidence source_evidence_literature NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance.
- NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_assertion SIO_000772 21148071 NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance.
- NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_assertion wasDerivedFrom befree-2016 NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance.
- NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_assertion wasGeneratedBy ECO_0000203 NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance.
- befree-2016 importedOn "2016-02-19" NP858185.RA-0g6S-Pp797a2Ublzx93gISnjYM67sQhzr3DDARVq8c130_provenance.